Geneos Wealth Management’s Morgan Stanley MS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$741K Sell
4,500
-69,042
-94% -$12M 0.02% 583
2025
Q4
$13.1M Sell
73,542
-1,036
-1% -$173K 0.32% 67
2025
Q3
$11.9M Sell
74,578
-2,171
-3% -$321K 0.3% 77
2025
Q2
$10.8M Sell
76,749
-49,001
-39% -$6.02M 0.26% 92
2025
Q1
$15.3M Buy
125,750
+85,395
+212% +$11M 0.22% 115
2024
Q4
$5.07M Buy
40,355
+875
+2% +$108K 0.18% 131
2024
Q3
$4.12M Buy
39,480
+3,332
+9% +$336K 0.16% 156
2024
Q2
$3.51M Buy
36,148
+996
+3% +$94.8K 0.16% 146
2024
Q1
$3.31M Buy
35,152
+2,403
+7% +$212K 0.15% 171
2023
Q4
$3.05M Sell
32,749
-475
-1% -$38K 0.15% 164
2023
Q3
$2.71M Buy
33,224
+677
+2% +$58.8K 0.14% 171
2023
Q2
$2.78M Buy
32,547
+1,691
+5% +$145K 0.15% 169
2023
Q1
$2.71M Sell
30,856
-4,783
-13% -$446K 0.16% 158
2022
Q4
$3.03M Buy
35,639
+2,321
+7% +$198K 0.18% 134
2022
Q3
$2.63M Sell
33,318
-2,782
-8% -$234K 0.18% 131
2022
Q2
$2.77M Buy
36,100
+2,256
+7% +$185K 0.14% 171
2022
Q1
$2.96M Buy
33,844
+6,677
+25% +$644K 0.13% 175
2021
Q4
$2.67M Buy
27,167
+1,345
+5% +$134K 0.1% 206
2021
Q3
$2.56M Buy
25,822
+2,381
+10% +$236K 0.1% 209
2021
Q2
$2.16M Buy
23,441
+416
+2% +$35.7K 0.08% 229
2021
Q1
$1.9M Sell
23,025
-1,156
-5% -$88.6K 0.05% 296
2020
Q4
$1.72M Buy
24,181
+20,304
+524% +$1.16M 0.07% 257
2020
Q3
$182K Sell
3,877
-887
-19% -$44.7K 0.01% 715
2020
Q2
$224K Sell
4,764
-86
-2% -$3.61K 0.01% 634
2020
Q1
$164K Sell
4,850
-1,851
-28% -$87.2K 0.01% 680
2019
Q4
$342K Sell
6,701
-576
-8% -$27.3K 0.02% 532
2019
Q3
$311K Sell
7,277
-7,658
-51% -$327K 0.02% 517
2019
Q2
$654K Sell
14,935
-59
-0.4% -$2.63K 0.04% 352
2019
Q1
$632K Buy
14,994
+18
+0.1% +$757 0.04% 347
2018
Q4
$589K Hold
14,976
0.04% 343
2018
Q3
$697K Buy
14,976
+188
+1% +$9.18K 0.05% 320
2018
Q2
$700K Hold
14,788
0.05% 273
2018
Q1
$797K Buy
14,788
+1,039
+8% +$57.5K 0.07% 243
2017
Q4
$721K Buy
13,749
+7,913
+136% +$400K 0.06% 262
2017
Q3
$281K Hold
5,836
0.03% 421
2017
Q2
$260K Sell
5,836
-71
-1% -$3.06K 0.03% 430
2017
Q1
$253K Sell
5,907
-1,242
-17% -$55.1K 0.03% 422
2016
Q4
$302K Sell
7,149
-329
-4% -$12.4K 0.04% 356
2016
Q3
$239K Sell
7,478
-499
-6% -$14.9K 0.03% 408
2016
Q2
$206K Buy
7,977
+1,143
+17% +$29.9K 0.03% 433
2016
Q1
$174K Buy
+6,834
New +$174K 0.03% 463

Other funds holding MS

Geneos Wealth Management's MS Position: Q1 2026 in Review

Geneos Wealth Management reduced its Morgan Stanley (MS) stake by 94% in Q1 2026, selling an estimated $12M and leaving 4,500 shares worth $741K. The position accounts for 0.02% of the portfolio, ranked #583.

Geneos Wealth Management first reported a position in MS in Q1 2016 and has held it in 41 quarters since. The position peaked at $15.3M in Q1 2025. 2,488 funds tracked by Wall St. Rank hold MS as of Q1 2026.

  • Geneos Wealth Management held 4,500 shares of Morgan Stanley worth $741K as of Q1 2026.
  • Geneos Wealth Management sold 69,042 Morgan Stanley shares in Q1 2026, an estimated $12M.
  • Morgan Stanley made up 0.02% of Geneos Wealth Management's portfolio in Q1 2026, its #583 holding.
  • Geneos Wealth Management first reported a position in Morgan Stanley in Q1 2016 and has held it in 41 quarters since.
  • Geneos Wealth Management's Morgan Stanley position peaked at $15.3M in Q1 2025.
  • 2,488 funds tracked by Wall St. Rank held Morgan Stanley as of Q1 2026.

Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.